Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases: Original article

Mycoses

Volumn 53, Issue 3, 2010, Pages 208-214

  Tobudic, Selma ^a   Lassnigg, Andrea ^a   Kratzer, Christina ^a   Graninger, Wolfgang ^a   Presterl, Elisabeth ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Amphotericin B; Biofilm; Candida albicans; Caspofungin; Posaconazole

Indexed keywords

AGAR; AMPHOTERICIN B; CASPOFUNGIN; POSACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; FUNGICIDAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; COLONY COUNT, MICROBIAL; ECHINOCANDINS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; TRIAZOLES;

CANDIDA ALBICANS;

EID: 77950809214     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01690.x     Document Type: Article

References (32)

1. Eggimann P, Garbino J, Pittet D. Management of Candida species infections in critically ill patients. Lancet Infect Dis 2003 3 : 772 785. (Pubitemid 37489961)
2. Gordon SM, Schmitt SK, Jacobs M et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg 2001 72 : 725 730. (Pubitemid 32846217)
3. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003 3 : 685 702. (Pubitemid 37345347)
4. Ramage G, Saville SP, Thomas DP et al. Candida biofilms: an update. Eukaryot Cell 2005 4 : 633 638. (Pubitemid 40600417)
5. Ramage G, Martinez JP, Lopez-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006 6 : 979 986. (Pubitemid 44568854)
6. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004 350 : 1422 1429. (Pubitemid 38419996)
7. Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerg Infect Dis 2004 10 : 14 9.
8. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007 7 : 645 657. (Pubitemid 47444563)
9. Sherman-Weber S, Axelrod P, Suh B et al. Infective endocarditis following orthotopic heart transplantation: 10 cases and a review of the literature. Transpl Infect Dis 2004 6 : 165 170. (Pubitemid 40516684)
10. Pasqualotto AC, Denning DW. New and emerging treatments for fungal infections. J Antimicrob Chemother 2008 61 (Suppl. 1 i19 30.
11. Chandra J, Kuhn DM, Mukherjee PK et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001 183 : 5385 5394. (Pubitemid 32802612)
12. Ramage G, Vande WK, Wickes BL et al. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001 45 : 2475 2479. (Pubitemid 32801898)
13. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts - Second Edition: Approved Standard M 27-A2.
14. Nguyen MH, Clancy CJ, Yu VL et al. Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia J Infect Dis 1998 177 : 425 430.
15. Pfaller MA, Diekema DJ, Ostrosky-Zeichner L et al. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol 2008 46 : 2620 2629.
16. Cocuaud C, Rodier MH, Daniault G et al. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother 2005 56 : 507 512. (Pubitemid 41264128)
17. Chabrier-Rosello Y, Foster TH, Perez-Nazario N et al. Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity. Antimicrob Agents Chemother 2005 49 : 4288 4295. (Pubitemid 41400976)
18. Walsh TJ, Rex JH. All catheter-related candidemia is not the same: assessment of the balance between the risks and benefits of removal of vascular catheters. Clin Infect Dis 2002 34 : 600 602.
19. Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000 46 : 397 403.
20. Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 2006 55 : 999 1008.
21. Parahitiyawa NB, Samaranayake YH, Samaranayake LP et al. Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device. APMIS 2006 114 : 298 306.
22. Al-Fattani MA, Douglas LJ. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother 2004 48 : 3291 3297.
23. Mateus C, Crow SA Jr., Ahearn DG. Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole. Antimicrob Agents Chemother 2004 48 : 3358 3366. (Pubitemid 39129331)
24. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998 11 : 382 402.
25. Kuhn DM, Ghannoum MA. Candida biofilms: antifungal resistance and emerging therapeutic options. Curr Opin Investig Drugs 2004 5 : 186 197.
26. Stevens DA, Espiritu M, Parmar R. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 2004 48 : 3407 3411. (Pubitemid 39129338)
27. Melo AS, Colombo AL, rthington-Skaggs BA. Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob Agents Chemother 2007 51 : 3081 3088.
28. Kuhn DM, George T, Chandra J et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002 46 : 1773 1780. (Pubitemid 34535196)
29. Bachmann SP, Vandewalle K, Ramage G et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002 46 : 3591 3596. (Pubitemid 35192931)
30. Katragkou A, Chatzimoschou A, Simitsopoulou M et al. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob Agents Chemother 2008 52 : 357 360.
31. Ramage G, Vandewalle K, Bachmann SP et al. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 2002 46 : 3634 3636. (Pubitemid 35192940)
32. Mukherjee PK, Chandra J, Kuhn DM et al. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 2003 71 : 4333 4340. (Pubitemid 36919897)